HawkEye 360, Inc. — Q3 2026 Form 10-Q
Reporting period: Three and nine months ended September 30, 2026; comparisons are with the corresponding 2025 periods. Amounts are in U.S. dollars. HawkEye 360 provides space-based radio-frequency signals intelligence, analytics, hardware and related services, primarily to U.S. and allied government customers. Its constellation includes more than 30 satellites. The company completed its IPO on May 8, 2026, and acquired Innovative Signal Analysis (ISA) in December 2025.
Key financial metrics
| Metric | Q3 2026 | Q3 2025 | Nine months 2026 | Nine months 2025 |
|---|---|---|---|---|
| Total revenue | $59.3 million | $32.2 million | $158.9 million | $81.8 million |
| Operating income (loss) | $(4.4) million | $1.7 million | $(21.5) million | $0.5 million |
| Net income (loss) | $(0.2) million | $1.7 million | $(24.4) million | $1.7 million |
| Operating cash flow | $9.6 million | $4.0 million | $18.0 million | $1.1 million |
| Capital expenditures | $9.5 million | $9.9 million | $19.8 million | $19.1 million |
| Free cash flow (non-GAAP) | $0.1 million | $(6.0) million | $(1.8) million | $(18.0) million |
| Adjusted EBITDA (non-GAAP) | $13.3 million | $9.6 million | $27.7 million | $21.2 million |
Margins and costs: The filing does not provide a clear gross-margin figure. Direct cost of sales was 29% of revenue in Q3 2026 versus 17% a year earlier, and 30% for the first nine months versus 19%. Nine-month operating expenses rose 122% to $180.5 million, faster than revenue growth of 94%.
Liquidity and debt: At September 30, cash and cash equivalents were $494.9 million, with $6.6 million of restricted cash. The company had no long-term debt and no borrowings under its $125 million revolving facility; the full facility was available. It repaid approximately $49.5 million of prior loans using IPO proceeds. Management believes cash and operating cash flows will meet liquidity needs for at least twelve months after the filing.
Material changes and business developments
- Revenue grew 84% in Q3 and 94% in the first nine months. ISA contributed $19.5 million of Q3 revenue and $48.8 million for the nine-month period. International revenue growth was attributed primarily to stronger RF data sales; U.S. growth included ISA, partly offset by lower RF data sales in government and other business.
- Revenue from related parties fell to zero in Q3 from $4.8 million in Q3 2025; the company says the relevant customer ceased to be a related party following the IPO.
- Despite higher revenue, Q3 operating results shifted from operating income to a loss; nine-month results shifted from modest net income to a $24.4 million net loss. Higher personnel and stock-based compensation, ISA-related costs, SG&A, and depreciation and amortization contributed to expense growth.
- The IPO generated $478.4 million gross and $437.5 million net proceeds. Preferred stock converted into common stock; 99.1 million shares were outstanding at September 30 and 99.3 million at November 9, 2026.
- Backlog was $300.3 million at September 30, versus $302.7 million at December 31, 2025. Remaining performance obligations were approximately $132.8 million; $100.0 million relates to a dedicated-access agreement with revenue scheduled at $5.0 million per quarter beginning in Q2 2027. Backlog and remaining obligations are not assured revenue; many customer contracts permit termination for convenience.
Outlook, risks and unusual items
- Guidance: The filing provides no specific revenue, earnings or margin guidance. Management describes plans to expand satellite and processing capabilities and develop faster, more automated analytics. Its estimated $34 billion total addressable market by 2030 is a management estimate, not a financial forecast.
- Profitability and execution: The company reports a history of losses and warns that it may not achieve or sustain profitability. It expects continued investment and higher public-company costs. Growth, integration of ISA, contract performance, hiring and cost control remain important execution factors.
- Government and customer exposure: A substantial portion of business depends on U.S. and allied government budgets, contract awards and procurement timing. Contracts may be terminated, and backlog may not convert to revenue. Revenue is concentrated among a limited number of customers; in Q3, four customers each accounted for at least 10% of revenue, with the largest listed share at 16%.
- Internal controls: Management concluded disclosure controls were not effective at September 30 because of material weaknesses. These concern stock-option compensation controls at HawkEye and segregation of duties, financial close/reporting, transaction-process controls and IT access controls at ISA. Remediation is underway but not yet complete.
- Investigation: ISA received a U.S. Department of Justice civil investigative demand in September 2025 concerning cybersecurity requirements on certain government contracts under a False Claims Act investigation. HawkEye says it is cooperating; timing and outcome are uncertain, and the filing says a material impact is possible depending on the outcome.
- Other items and contingencies: Nine-month results include a $2.7 million loss on extinguishment of debt and $5.7 million of fair-value losses, primarily from warrants and ISA-related deferred and contingent consideration. A $0.5 million vendor-claim settlement was recorded in Q1. International offset agreements had an estimated $27.0 million notional value; actual cash costs are generally a fraction of notional value, but penalties may apply for nonperformance.
- Other material risks include satellite or launch disruption, supply-chain and tariff pressures, cybersecurity and export-control compliance, acquisition integration, and the possibility of additional financing or shareholder dilution. No material subsequent events were reported through November 12, 2026.
Investor verification priorities
- Assess whether revenue growth, particularly ISA contributions and international RF data sales, can be sustained while direct and indirect delivery costs and SG&A increase.
- Review cash conversion: nine-month operating cash flow was positive, but free cash flow remained negative after $19.8 million of capital expenditures; distinguish operating performance from working-capital timing and IPO proceeds.
- Track remediation and testing of the disclosed material weaknesses, and whether future filings report effective controls or identify additional deficiencies.
- Monitor the DOJ investigation involving ISA, including any updates on scope, potential exposure or contract consequences.
- Evaluate backlog quality and customer termination rights, funding and task-order dependence, customer concentration, and the timing and collectability of the $100 million dedicated-access agreement.
- Check future satellite investment needs, contract performance and offset obligations, as well as equity compensation, outstanding awards and potential dilution.